The cc-TDI Youth Art & Writing Contest invites K–12 students to showcase their creativity while joining the fight against childhood cancer. Whether through visual art
To Donate to this cause, please click here Throughout Maya’s brave journey, our family found both hope and guidance in cc-TDI’s work, making this cause
This year marks 10 years of innovation and progress at cc-TDI, and we’re proud to reflect on the milestone we’ve reached—because of you. Despite a
We’re celebrating 10 years of impact at cc-TDI! Thanks to your partnership, we’ve translated two drugs into three national and international clinical trials, published 68
Be part of our team, uncovering how childhood cancers work – and helping find the treatments that could go to clinical trials to improve outcomes.
In a groundbreaking study, Entinostat as a combinatorial therapeutic for rhabdomyosarcoma, published earlier this week in Scientific Reports, researchers with the Children’s Cancer Therapy Development
The Children’s Cancer Therapy Development Institute (cc-TDI) is delighted to welcome former Intel Executive, Claire Newman, as their new Executive Director on July 1st. Claire
In March the Children’s Cancer Therapy Development Institute (cc-TDI) announced its partnership with Team KOODAC (Knock Out Oncogenic Drivers and Curing Childhood Cancer), a global
We are thrilled to present the 2023 inaugural Impact Report for the Children’s Cancer Therapy Development Institute (cc-TDI), a testament to our joint commitment to advancing childhood
In a significant stride towards advancing pediatric cancer research, we are thrilled to announce that the state of Oregon has allocated a generous $1 million
Are you a PhD developmental biologist, biochemist, molecular biologist, biomedical engineer or stem cell biologist interested in changing paradigms and outcomes for cancers of children,
Be part of our team, uncovering how childhood cancers work – and helping find the treatments that could go to clinical trials to improve outcomes.
Be part of our team, uncovering how childhood cancers work – and helping find the treatments that could go to clinical trials to improve outcomes.
In the summer of 2019, Amy Rogers was working with Enactus, the student group at North Central College in Naperville, Illinois. The group focuses heavily
Be part of our team, uncovering how childhood cancers work – and helping find the treatments that could go to clinical trials to improve outcomes.
Postdoctoral Fellowship or Senior Scientist Position Portland, Oregon USA Are you a PhD developmental biologist, biochemist, molecular biologist, biomedical engineer or stem cell biologist interested
Are you a PhD biochemist, molecular biologist, biomedical engineer or stem cell biologist interested to change paradigms and outcomes for cancers of children, adolescents and
Be part of our team, uncovering how childhood cancers work – and helping find the treatments that could go to clinical trials to improve outcomes.
Be part of our team, uncovering how childhood cancers work – and helping find the treatments that could go to clinical trials to improve outcomes.
The cc-TDI Youth Art & Writing Contest invites K–12 students to showcase their creativity while joining the fight against childhood cancer. Whether through visual art
To Donate to this cause, please click here Throughout Maya’s brave journey, our family found both hope and guidance in cc-TDI’s work, making this cause
This year marks 10 years of innovation and progress at cc-TDI, and we’re proud to reflect on the milestone we’ve reached—because of you. Despite a
We’re celebrating 10 years of impact at cc-TDI! Thanks to your partnership, we’ve translated two drugs into three national and international clinical trials, published 68
Be part of our team, uncovering how childhood cancers work – and helping find the treatments that could go to clinical trials to improve outcomes.
In a groundbreaking study, Entinostat as a combinatorial therapeutic for rhabdomyosarcoma, published earlier this week in Scientific Reports, researchers with the Children’s Cancer Therapy Development
The Children’s Cancer Therapy Development Institute (cc-TDI) is delighted to welcome former Intel Executive, Claire Newman, as their new Executive Director on July 1st. Claire
In March the Children’s Cancer Therapy Development Institute (cc-TDI) announced its partnership with Team KOODAC (Knock Out Oncogenic Drivers and Curing Childhood Cancer), a global
We are thrilled to present the 2023 inaugural Impact Report for the Children’s Cancer Therapy Development Institute (cc-TDI), a testament to our joint commitment to advancing childhood
In a significant stride towards advancing pediatric cancer research, we are thrilled to announce that the state of Oregon has allocated a generous $1 million
Are you a PhD developmental biologist, biochemist, molecular biologist, biomedical engineer or stem cell biologist interested in changing paradigms and outcomes for cancers of children,
Be part of our team, uncovering how childhood cancers work – and helping find the treatments that could go to clinical trials to improve outcomes.
Be part of our team, uncovering how childhood cancers work – and helping find the treatments that could go to clinical trials to improve outcomes.
In the summer of 2019, Amy Rogers was working with Enactus, the student group at North Central College in Naperville, Illinois. The group focuses heavily
Be part of our team, uncovering how childhood cancers work – and helping find the treatments that could go to clinical trials to improve outcomes.
Postdoctoral Fellowship or Senior Scientist Position Portland, Oregon USA Are you a PhD developmental biologist, biochemist, molecular biologist, biomedical engineer or stem cell biologist interested
Are you a PhD biochemist, molecular biologist, biomedical engineer or stem cell biologist interested to change paradigms and outcomes for cancers of children, adolescents and
Be part of our team, uncovering how childhood cancers work – and helping find the treatments that could go to clinical trials to improve outcomes.
Be part of our team, uncovering how childhood cancers work – and helping find the treatments that could go to clinical trials to improve outcomes.
EIN: 46-5759569
cc-TDI is a qualified 501(c)(3) charitable organization registered with the IRS
(consult with a CPA regarding specific tax implications)
Copyright 2024 – Children’s Cancer Therapy Development Institute